Trials / Sponsors / Imbioray (Hangzhou) Biomedicine Co., Ltd.
Imbioray (Hangzhou) Biomedicine Co., Ltd.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma Renal Cell Carcinoma (RCC) | Phase 2 | 2025-08-10 |
| Recruiting | The Safety, Tolerability, and Efficacy of IBR900 Cell Injection in Relapsed/Refractory B-cell Non Hodgkin Lymp Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | Phase 1 | 2025-07-20 |
| Unknown | Study of IBR733 Cell Injection in Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 1 | 2024-02-01 |
| Unknown | Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors Solid Tumors | Phase 1 | 2023-09-01 |